Accendra Health, Inc.

NYSE:ACH

Medical - Distribution

Healthcare
$0.71 +3.64%

+$0.12 today

Market cap
$54.22M
Beta
1.63
P/E (TTM)
-0.2
EPS (TTM)
-$14.11
52W Low $1.84High $9.55

Volume 1.41M

Average 0.83M

ACH Long-term Debt

Borrowings due after more than one year.

Accendra Health, Inc.NYSE: ACH

Long-term Debt · Q1 FY2026 · quarter ended Mar 2026

Long-term debt falls 19.5% from a year ago

Long-term debt stood at $1.52B at the end of Q1 FY2026, down 19.5% from a year earlier and down 18.6% from the prior quarter. Over 3 fiscal years it compounded at -8.9% a year.

Context

  • Long-term debt amounted to 63.0% of total assets at the end of Q1 FY2026, up 24.1 pp from a year earlier.
  • Long-term debt increased in 1 of the last 3 fiscal years.

What to watch

Whether long-term debt keeps falling in the next quarterly balance sheet after a -19.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.52B-18.6% QoQ
Last fiscal yearDec 2025
$1.87B+3.8% YoY
Year agoMar 2025
$1.89B-19.5% since
Long-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-19.5%——
1 year+3.8%——
3-year CAGR-8.9%——
5-year CAGR——
10-year CAGR——

Long-term Debt history

USD · from the balance sheet

Latest · FY2025
1.87B USD
Year-over-year change
+3.8%
4-year CAGR
+18.9%

Long-term Debt vs competitors

How ACH compares with its peers on the latest reported figures

  • Peers report in different currencies, so long-term debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -19.5% is the 5th highest of 7, against a peer median of -2.1%.
  • Long-term debt amounts to 63.0% of total assets for ACH, versus a peer median of 10.0%.
ACH Competitors
Long-term Debt for ACH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ACHAccendra Health, Inc.Mar 2026$1.52B USD-19.5%-8.9%63.0%
CGCCanopy Growth CorporationMar 2026CA$217.12M CAD-27.6%-26.1%19.4%
OMOutset Medical, Inc.Mar 2026$96.94M USD+3.0%-0.0%38.9%
CVRXCVRx, Inc.Mar 2026$59.03M USD+19.7%+95.2%59.2%
EDITEditas Medicine, Inc.Mar 2026$47.18M USD——31.6%
SGHTSight Sciences, Inc.Mar 2026$36.74M USD-7.2%+6.6%33.5%
BIOABioAge Labs, Inc.Mar 2026$2.23M USD+111.1%+1.1%0.6%
ACRSAclaris Therapeutics, Inc.Mar 2026$0 USD——0.0%
ALLOAllogene Therapeutics, Inc.Mar 2026$0 USD——0.0%
CABACabaletta Bio, Inc.Mar 2026$0 USD——0.0%
HITIHigh Tide Inc.Apr 2026CA$0 CAD-100.0%+69.1%0.0%
Peer median (excluding ACH) —-2.1%+3.8%10.0%

Competitors are the stored peer set for ACH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents55.71M69.47M243.04M49.38M281.99M
Short-term Investments00000
Net Receivables681.56M763.5M598.26M690.24M95.91M
Inventory1.5B1.33B1.11B1.13B74.44M
Other Current Assets88.56M128.64M150.89M149.52M95.54M
Total Current Assets2.32B2.3B2.1B2.02B547.87M
Property, Plant & Equipment (Net)511.24M858.93M840.51M864.97M365.26M
Goodwill390.19M1.64B1.64B1.33B1.23B
Intangible Assets243.75M483.74M361.84M296.73M136.47M
Long-term Investments16.32M15.46M8.45M6.11M1.34M
Tax Assets00(8.45M)00
Other Non-current Assets53.25M96.26M149.35M134.05M172.69M
Total Non-current Assets1.21B3.09B2.99B2.63B1.9B
Total Assets3.54B5.39B5.09B4.66B2.45B
Account Payables1B1.15B1.17B1.25B363.57M
Short-term Debt43.85M15.38M204.08M40M293.27M
Tax Payables00000
Deferred Revenue00116.4M00
Other Current Liabilities182.35M227.44M191.66M425.54M220.81M
Total Current Liabilities1.34B1.57B1.89B1.87B947.08M
Long-term Debt936.23M2.47B1.88B1.8B1.87B
Deferred Tax Liabilities35.31M60.83M41.65M22.46M0
Deferred Revenue (Non-current)00000
Other Non-current Liabilities108.94M114.94M122.59M100.13M25.15M
Total Non-current Liabilities1.25B2.87B2.28B2.22B1.97B
Total Liabilities2.6B4.44B4.17B4.09B2.91B
Common Stock150.87M152.56M153.09M154.4M152.78M
Retained Earnings387.62M410.01M368.71M6.02M(1.08B)
Accumulated OCI(40.59M)(35.85M)(31.82M)(49.34M)(885K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity938.5M945.6M924.17M565.23M(460.98M)
Total Debt1.15B2.79B2.41B2.14B2.23B
Net Debt1.1B2.72B2.16B2.09B1.95B

Accendra Health, Inc.

NYSE:ACH

Intrinsic Alpha fair value

Locked

Current Price

$0.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.